Prevalence of Specific and Non-Specific Markers and Factors Associated with Hepatitis B Virus in Health Science Students and Healthcare Workers in the City of Conakry, Guinea
Introduction: Hepatitis B virus (HBV) is a DNA virus that causes inflammation of the liver. It is transmitted through unprotected sexual intercourse, contact with infected blood, and vertically from mother to child. The risk of infection is very high in healthcare settings, especially for under-equipped and less experienced staff. The objective of this study was to determine the prevalence of specific and non-specific markers and factors associated with hepatitis B among health science students and healthcare personnel in the city of Conakry. Methods: This was a prospective cohort study of staff at national hospitals and municipal medical centers, as well as health science students at public and private universities and health schools in the city of Conakry, covering 24 institutions. The data collected included sociodemographic information and 2 ml of blood in a tube without anticoagulant, which was tested for specific and non-specific markers were detected using the chemiluminescence method with the Architect 1000 i SR analyzer (Abbott Industries) and non-specific markers using the URIT 8021A analyzer, which uses a monochromatic light source to measure the absorbance of light passing through a reaction mixture containing the sample and reagents at the immuno-serology laboratory of the National Institute of Health. Statistical analyses were performed using R software version 4.4.0. The p-value was calculated to determine the existence of a statistically significant link between the study variables. Results: A total of 3,041 healthcare workers and students participated in the study, of whom 257 were HBsAg carriers (8.5%). All of these HBsAg-positive participants also carried total anti-HBc antibodies, 2.3% were HBeAg carriers, and 1.2% carried anti-HBs antibodies. Conclusion: The prevalence of hepatitis B among healthcare workers and health science students, comparable to that of the general population, reveals a striking reality: hepatitis B knows no professional boundaries.
References
[1]
Gerlich, W.H. (2013) Medical Virology of Hepatitis B: How It Began and Where We Are Now. VirologyJournal, 10, Article No. 239. https://doi.org/10.1186/1743-422x-10-239
[2]
Blumberg, B.S. (1965) A “New” Antigen in Leukemia Sera. JAMA: TheJournaloftheAmericanMedicalAssociation, 191, 541-546. https://doi.org/10.1001/jama.1965.03080070025007
[3]
Blumberg, B.S. (1977) Australia Antigen and the Biology of Hepatitis B. Science, 197, 17-25. https://doi.org/10.1126/science.325649
[4]
Dane, D.S., Cameron, C.H. and Briggs, M. (1970) Virus-Like Particles in Serum of Patients with Australia-Antigen-Associated Hepatitis. TheLancet, 295, 695-698. https://doi.org/10.1016/s0140-6736(70)90926-8
[5]
Walter, E., Keist, R., Niederöst, B., Pult, I. and Blum, H.E. (1996) Hepatitis B Virus Infection of Tupaia Hepatocytes in Vitro and in Vivo. Hepatology, 24, 1-5. https://doi.org/10.1002/hep.510240101
[6]
Barker, L.F. and Murray, R. (1972) Relationship of Virus Dose to Incubation Time of Clinical Hepatitis and Time of Appearance of Hepatitis’ Associated Antigen. TheAmericanJournaloftheMedicalSciences, 263, 27-33. https://doi.org/10.1097/00000441-197201000-00005
[7]
Rehermann, B. and Nascimbeni, M. (2005) Immunology of Hepatitis B Virus and Hepatitis C Virus Infection. NatureReviewsImmunology, 5, 215-229. https://doi.org/10.1038/nri1573
[8]
Liang, J.T. (2009) Hepatitis B: The Virus and Disease. Hepatology, 49, S13-S21. https://doi.org/10.1002/hep.22881
[9]
Brian, J.M. (2008) Natural History of Chronic Hepatitis B—Clinical Implications. The Medscape Journal of Medicine, 10, Article 91.
[10]
Schweitzer, I.L., Dünn, A.E.G., Peters, R.L. and Spears, R.L. (1973) Viral Hepatitis B in Neonates and Infants. TheAmericanJournalofMedicine, 55, 762-771. https://doi.org/10.1016/0002-9343(73)90257-x
[11]
Yan, H., Zhong, G., Xu, G., He, W., Jing, Z., Gao, Z., etal. (2012) Sodium Taurocholate Cotransporting Polypeptide Is a Functional Receptor for Human Hepatitis B and D Virus. eLife, 1, e00049. https://doi.org/10.7554/elife.00049
[12]
Li, H., Zhuang, Q., Wang, Y., Zhang, T., Zhao, J., Zhang, Y., etal. (2014) HBV Life Cycle Is Restricted in Mouse Hepatocytes Expressing Human NTCP. Cellular&MolecularImmunology, 11, 175-183. https://doi.org/10.1038/cmi.2013.66
[13]
Schmitz, A., Schwarz, A., Foss, M., Zhou, L., Rabe, B., Hoellenriegel, J., etal. (2010) Nucleoporin 153 Arrests the Nuclear Import of Hepatitis B Virus Capsids in the Nuclear Basket. PLOSPathogens, 6, e1000741. https://doi.org/10.1371/journal.ppat.1000741
[14]
Guo, H., Jiang, D., Zhou, T., Cuconati, A., Block, T.M. and Guo, J. (2007) Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: An Intermediate of Covalently Closed Circular DNA Formation. JournalofVirology, 81, 12472-12484. https://doi.org/10.1128/jvi.01123-07
[15]
Seeger, C. and Mason, W.S. (2015) Molecular Biology of Hepatitis B Virus Infection. Virology, 479, 672-686. https://doi.org/10.1016/j.virol.2015.02.031
[16]
Tan, Z., Pionek, K., Unchwaniwala, N., Maguire, M.L., Loeb, D.D. and Zlotnick, A. (2015) The Interface between Hepatitis B Virus Capsid Proteins Affects Self-Assembly, Pregenomic RNA Packaging, and Reverse Transcription. JournalofVirology, 89, 3275-3284. https://doi.org/10.1128/jvi.03545-14
[17]
Souare, O.I., Huws, J., Djenabou, D. and Kadiatou, D. (2024) Epidemiology of Viral Hepatitis B and C in Guinea: Scooping Review. Health Research in Africa, 2, 1-10.
[18]
Keita, M., Fadiga, A.G., Soumah, M.M., Sylla, D., Traore, F.A., Biané, B., etal. (2014) Co-infection VIH et virus de l’hépatite B au service d’hématologie de l’hôpital national Ignace Deen (Guinée-Conakry). AnnalesdeDermatologieetdeVénéréologie, 141, S442. https://doi.org/10.1016/j.annder.2014.09.479
[19]
ONU (2022) Plus de 90 millions d’Africains infectés par l’hépatite B ou C (OMS). ONU Info 2022. https://news.un.org/fr/story/2022/07/1124552
[20]
Maamor, N.H., Muhamad, N.A., Mohd Dali, N.S., Abdul Mutalip, M.H., Leman, F.N., Aris, T., etal. (2022) Seroprevalence of Hepatitis B among Healthcare Workers in Asia and Africa and Its Association with Their Knowledge and Awareness: A Systematic Review and Meta-Analysis. FrontiersinPublicHealth, 10, Article 859350. https://doi.org/10.3389/fpubh.2022.859350
[21]
Helcl, J., Cástková, J., Benes, C., Novotna, L., Sepkowitz, K.A. and DeHovitz, J.A. (2000) Control of Occupational Hepatitis B among Healthcare Workers in the Czech Republic, 1982 to 1995. InfectionControl&HospitalEpidemiology, 21, 343-346. https://doi.org/10.1086/501771
[22]
Pietra, V., Kiema, D., Sorgho, D., Kabore, S.P.C.G., Mande, S., Castelli, F., etal. (2008) Prévalence des marqueurs du virus de l’hépatite B et des anticorps contre le virus de l’hépatite C parmi le personnel du District Sanitaire de Nanoro, Burkina Faso [Prevalence of Hepatitis B Virus Markers and Hepatitis C Virus Antibodies in Health Personnel in the District of Nanoro, Burkina Faso]. Sciences de la Santé, 31, 53-59.
[23]
Camara, A., Thea, E., Haba, I.N., Youla, Y., Diallo, I.S., Diallo, M.S., etal. (2024) Seroprevalence of Human Immunodeficiency Virus and Hepatitis B in Blood Donors at the N’Zérékoré Regional Blood Transfusion Centre in Guinea. OpenJournalofImmunology, 14, 33-45. https://doi.org/10.4236/oji.2024.142004
[24]
Pu, Z., Li, D., Wang, A., Su, H., Shao, Z., Zhang, J., etal. (2015) Epidemiological Characteristics of the Carriers with Coexistence of HBsAG and Anti-HBs Based on a Community Cohort Study. JournalofViralHepatitis, 23, 286-293. https://doi.org/10.1111/jvh.12492
[25]
Vaillant, A. (2021) Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure. Viruses, 13, Article 745. https://doi.org/10.3390/v13050745
[26]
Tadesse, S., Munshea, A., Gelaw, B., Peshu, N., Tesfa, E., Mekonnen, F., etal. (2025) Prevalence of Hepatitis B Virus Infection and Its Associated Factors in Ethiopia: A Recent Systematic Review and Meta-Analysis. BMCInfectiousDiseases, 25, Article No. 749. https://doi.org/10.1186/s12879-025-11150-8
